Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens
The overall prevalence of VF was low for all regimens. B/F/TAF was associated with a numerically lower prevalence of RAMs at VF compared with DTG/3TC and CAB + RPV. These observational findings highlight the importance of monitoring resistance patterns to optimize HIV treatment outcomes.
Authors
- Travis Lim (ORCID: https://orcid.org/0000-0003-1662-7329)
- V. Calvez
- Anne‐Geneviève Marcelin (ORCID: https://orcid.org/0000-0003-4808-8999)
- Marc Wirden (ORCID: https://orcid.org/0009-0003-3723-4142)
- Guillaume Barriere (ORCID: https://orcid.org/0009-0006-4776-4827)
- D. Descamps
- Cathia Soulié (ORCID: https://orcid.org/0009-0008-2032-4148)
- Joshua Gruber
- Charlotte Charpentier
- Neia Prata Menezes
Institutions
- Inserm (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Gilead Sciences (United States) (US)
- Gilead Sciences (France) (FR)
Publication Details
- Journal
- AIDS
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1097/qad.0000000000004438
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00